Access TOC
Get a SampleNovember 2024
The global polymerase chain reaction market size accounted for USD 9.55 billion in 2024, grew to USD 10.46 billion in 2025 and is predicted to surpass around USD 23.66 billion by 2034, representing a healthy CAGR of 9.50% between 2024 and 2034. The North America polymerase chain reaction market size is calculated at USD 3.82 billion in 2024 and is expected to grow at a fastest CAGR of 9.61% during the forecast year.
The global polymerase chain reaction market size is estimated at USD 9.55 billion in 2024 and is anticipated to reach around USD 23.66 billion by 2034, expanding at a CAGR of 9.50% from 2024 to 2034.
The U.S. polymerase chain reaction market size is evaluated at USD 2.67 billion in 2024 and is predicted to be worth around USD 6.76 billion by 2034, rising at a CAGR of 9.71% from 2024 to 2034.
North American region has dominated the market for the polymerase chain reaction in the past and it is expected to grow well in the coming years. Due to an increase in the number of initiatives taken by the government which are extremely favorable for the growth of the market there has been an adoption of regulatory guidelines which are flexible and support the growth of the market in the North American region.
Polymerase chain reaction technique is largely used in the modern form of biology. It is extremely important as well as powerful chain reaction. Polymerase chain reaction is a technique of the molecular form which helps in generating about millions of copies in a given region for the specific DNA strand. This happens to be an in vitro amplification technique. Increase in the cases of various infectious diseases and different types of genetic disorders have created a greater demand for these techniques.
Increased use of the polymerase chain reaction for the diagnosis of cancer is expected to drive the market growth in the coming years. All of these factors are responsible for creating a greater demand for this technique in the coming years period constant research and development activities for providing innovative molecular biology and forensic science as there has been a great demand for genetic engineering as well as the personalized medicines the market is expected to grow well in the given period of time.
During the outbreak of COVID-19 pandemic there was a greater demand for precise diagnosis of the disease. A large demand was created for the polymerase chain reactions from many countries across the globe. Most of the diagnosis were carried out through the use of the polymerase chain reaction as this technique was seen as one of the most reliable ones. The demand for the assays, reagents and different products Warren great demand during the pandemic from all the developing as well as the developed nations. Most of the market players like the Thermo Fisher Scientific had seen and increase in the revenue during the pandemic. As compared to the previous years the revenue generated by Thermo Fisher Scientific life sciences was about 77.5%. As the outbreak of COVID 9 pandemic prevail for a longer period of time many products were launched in the market due to which the market for the polymerase chain reaction had grown significantly during those years and it is expected to grow well in the coming years.
Polymerase in reaction the process used for amplification of a shorter region after DNA in vitro This reaction happens to be here process driven by the enzymes. Due to the amplification, the market for this technology is expected to grow. There has been a greater demand for various innovative devices and advancements in this technology and the latest innovations have introduced many devices of a miniature size in the market. These small devices or extremely beneficial for the healthcare providers as well as the patient size helps in providing many clinical benefits.
Across the globe many patients suffering with tuberculosis Has been a leading cause for the use of this technology. In the developing nations the cases of tuberculosis are more. In the past the number of people suffering with tuberculosis was about 10 million and the use of this technology for the diagnosis of this disease has grown drastically. polymerase chain reaction technology is used for the detection of the pulmonary tuberculosis. Indonesians like India and China the number of people suffering with this disease is more. The increasing prevalence of various types of the infectious diseases is expected to be the number one reason for the growth of the market during the forecast period. There has been a greater demand for the polymerase chain reaction devices in the recent years due to a greater demand for the diagnostic techniques of the digital kind. When most of the clinical testing provided across the globe the real time technology is used on a large scale. The amount of precision provided by the use of digital technology is expected to create a larger market for the polymerase chain reaction technology.
Constant research and development techniques have provided advanced systems for the detecting of diseases. Most of the professionals in the medical industry are shifting to the use of these devices. It is extremely beneficial in studying the jeans and the sales. It helps in detecting the presence of cancer and all of these reasons are expected to help in the growth of the market during the coming years. Increase in the geriatric population across the world and the growing cases of chronic diseases has led to a growth in the market.
Most of the opportunities provided in the market are due to an increasing need for the personalized type of medicines. In order to detect a disease the technology which will be able to gain information at the molecular base will be extremely beneficial. Polymerized chain reaction techniques are used on a large scale for all the screening methods. The biotechnology industry has gained traction due to the introduction of the polymerase chain reaction. Polymerase chain reaction is an important part of the life sciences as well as the pharmaceutical industry. As the devices are used on large scale for the discovering of the drugs the demand for the polymerase chain reaction technology is expected to grow well in the coming years.
In the recent years the demand for the molecular diagnostics for the respiratory infections has grown well due to the spread of the COVID-19 pandemic. There has also been an increase in the adoption of automation for processing a large number of the collected samples. In order to increase the capacity for testing and to reduce the amount of money spent on these tests a combination of the group testing and digital polymerase chain reaction shall be in demand. In order to reduce the use of the reagents and to improve the efficiency a group testing method was offered by an organization and due to this development, the use of the reagents was made efficiently. Due to the scarcity of reagents many manufacturers are making use of this method.
| Report Coverage | Details |
| Market Size in 2024 | USD 9.55 Billion |
| Market Size by 2034 | USD 23.66 Billion |
| Growth Rate from 2024 to 2034 | CAGR of 9.50% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2034 |
| Segments Covered | Type, Product, Application, Indication, End User, and Geography |
Depending upon the type, the others segment has had a largest market share in 2023. In the past the other segment has dominated as it includes the digital polymerase chain reaction and the real time polymerase chain reaction. As these techniques are used and adopted for large number of applications for the research field the market is expected to grow well. In order to detect the amplification, the RTPCR is more efficient in comparison to the other conventional polymerase chain reactions. Due to this ability the market is expected to grow well during the forecast period.
Constant research and development techniques have been beneficial in providing advancements and innovations in the product which have created more demand for the use of the technique in the diagnostics due to the automated systems. Constant launching off new products in the market shall drive the market growth during the forecast period. One of the polymerase chain reactions called the plasmonic PCR happens to be a low-cost option which helps in detecting the infections and the packaging at a greater rate.
On the basis of the products, the consumable and reagents segment is expected to have the largest market share in the coming years period. The market for the consumables and the reagents segment is expected to grow well due to a growing demand for them COVID-19 pandemic testing. As many new technologically advanced products for diagnosis or the devices for this diagnosis are available in the market the demand for these products is expected to grow well in the coming years.
Excellent in order to detect the RNA and DNA amplification or agent was launched in the year 2023 that would be helpful in increasing the speed of the procedures by the PCR Biosystems. There has been an increased focus on providing products that are convenient to use.
On the basis of application, the medical segment is expected to be used in the medical field. This segment is expected to dominate the market in the coming years period. The technique is used in various applications in the medical field including the research activities due to which the market is expected to grow well.
This technique is also used in detecting the mutations understanding the highly sensitive pathogens will drive the market growth in the coming years period in most of the hospitals as well as the diagnostic centers across the globe are making use of the polymerase chain reactions the market is expected to grow well. There has been an increased use of polymerase chain reaction technique in the ensuring of safety of the food items. It helps in detecting the pathogens present in the food. It has extremely important place in detecting the pathogens in meat which is expected to drive the market growth in the coming years.
By Type
By Product
By Application
By Indication
By End User
By Geography
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
November 2024
November 2024
December 2022
September 2024